Takeda

CINRYZE

Manufacturer:

Takeda

Cinryze HCPCS:

J0598

HCPCS Code Descriptor:

Injection, c-1 esterase inhibitor (human), cinryze, 10 units

Category:

J Code

Cinryze NDCs:

42227-0083-01

Primary Type:

Immunology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Cinryze:

CINRYZE is an Immunology drug manufactured by Takeda and administered via the Intravenous route of administration. The J Code: J0598 is aligned to the drug CINRYZE.

ACCESS PRICING AND MORE BY REGISTERING

J0598 Added Date:

January 1, 2010

J0598 Effective Date:

January 1, 2011

J0598 Termination Date:

HCPCS Active

Cinryze billing and coding information can be found through Takeda at the link below:
Cinryze patient assistance information can be found through OnePath Patient Support at the URL: https://www.cinryze.com/financial-support
CINRYZE prescribing information can be found at the link below:
Information regarding CINRYZE’s side effects can be found at MedlinePlus